A University of Melbourne research lab is partnering with genetic engineering company Colossal Biosciences to bring the thylacine back from extinction. [ + ]

Elevate will award up to 500 undergraduate and postgraduate scholarships to women in science, technology, engineering and mathematics over the next six years. [ + ]

Retinal layer thinning as a result of an MS relapse can predict the severity of future relapses and, hence, the likelihood of disability. [ + ]

The state-of-the-art facility, which is expected to produce up to 100 million mRNA respiratory vaccine doses annually, will be located at Monash's campus in Clayton. [ + ]

Researchers have found that people with PTSD and high psychopathological indications exhibit the same picture of bacteria in the saliva (a unique oral microbiotic signature). [ + ]

Researchers at the National Vaccine and Therapeutics Lab will turn vaccine and drug candidates into products that can be manufactured in large quantities for clinical trials. [ + ]

Investigating the impact of CRISPR technology on T cells, researchers detected a significant loss of genetic material in some treated cells. [ + ]

Getting children closer to green spaces as they grow up could improve their lung health, according to a study of 3278 children living in and around Porto, Portugal. [ + ]

A seasoned executive, Foster brings more than 25 years of experience in the healthcare industry. [ + ]

CUREator supports and accelerates the development of Australian biotech innovations, and has funded 23 projects across six states and territories. [ + ]

The Victorian mRNA Innovation Hub will work to develop next-generation mRNA vaccines and therapeutics to treat a range of diseases. [ + ]

The Australian Government has secured 450,000 doses of the new third-generation monkeypox vaccine by Bavarian Nordic, with the NSW rollout beginning on 8 August. [ + ]

Researchers created a method for detecting folding errors at early stages of neurodegenerative diseases, via the structure of dried protein and peptide solutions. [ + ]

Moderna's COVID-19 vaccine will be available to children aged six months to less than five years in certain at-risk population groups, with first doses to begin in September. [ + ]

While the majority of Australians support the use of animals in research, this support is highly conditional and most agree there needs to be more transparency. [ + ]